Katrina Megget, Author at

In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of

Chronic kidney disease: treating a silent killer

https://pharmaphorum.com/patients/chronic-kidney-disease-treating-a-silent-killer/

COVID-19 has changed everything – at least that’s David Hunt’s plan for pharmaceutical marketing. The former CEO of

The Considered pharmaceutical marketing experiment

https://pharmaphorum.com/sales-marketing/considered-pharmaceutical-marketing-experiment/

It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina

2021: the year mRNA therapeutics came of age

https://pharmaphorum.com/r-d/2021-the-year-mrna-therapeutics-came-of-age/

The race to find and bring vaccines to market to fight Covid was impressive. So too are the

The Covid cash cow – a look at the Covid vaccine sales figures

https://pharmaphorum.com/sales-marketing/phamra-covid-vaccine-cash-cow/

About Katrina Megget